Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001104659-24-022575 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | INSP | Rondoni John | CTO | A - Grant | $0.00 | +2,694 | 16.3K | +20% | $0 |
| D | 2024-02-13 | 2024-02-09 | INSP | Rondoni John | CTO | A - Grant | $0.00 | +4,376 | 4,376 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | A | A | 2,694 | $0.00 | 16,262 | D | — | — | (F1) Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents acontingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. (F2) Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan onDecember 31, 2023. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-09 | A | A | 4,376 | $0.00 | 4,376 | D | $194.87 · — to 2034-02-09 | 4,376 Common Stock | (F3) The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and becomeexercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |